Celularity Inc
For the period ended Dec 31, 2025. Filed Apr 30, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Apr 30, 2026
CELU$0.76-0.1%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Financial Statements and Supplementary Data
| Page | |
|---|---|
| Report of Independent Registered Public Accounting Firm (PCAOB ID No. 274) | 74 |
| Consolidated Balance Sheets | 75 |
| Consolidated Statements of Operations and Comprehensive Loss | 76 |
| Consolidated Statements of Stockholders’ (Deficit) Equity | 77 |
| Consolidated Statements of Cash Flows | 78 |
| Notes to Consolidated Financial Statements | 79 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.